Krsnaa Diagnostics Allots Preferential Warrants Worth ₹91.75 Crore to Promoters
Krsnaa Diagnostics Ltd · Others (Uncategorized) · 14 Oct 2026, 12:41 am
Krsnaa Diagnostics Allots Preferential Warrants Worth ₹91.75 Crore to Promoters Krsnaa Diagnostics allotted 16,21,000 fully convertible warrants on 13th Oct'26 at ₹566 each on a preferential basis to promoters, receiving an upfront 25% subscription amount of ₹22.94 crore. Allottees include promoter Rajendra Mutha (75,000 warrants) and promoter entity Krsna Diagnostics (Mumbai) Private Limited (15,46,000 warrants). The warrants are convertible into equity shares (face value ₹5) within 18 months upon paying the remaining 75%. Post-conversion, promoter and promoter group shareholding will increase from 27.11% to 29.70%.
Original exchange filing (PDF)
More announcements from Krsnaa Diagnostics Ltd
- Earnings Call Transcript for quarter and half year ended September 30, 2026 · 08 Nov 2026
- Intimation of Change in Corporate office of Registrar and Sahre Trasnfer Agent of the Company w.e.f. 1st December 2026. · 04 Nov 2026
- Audio recording of conference call for the quarter and half year ended September 30, 2026 · 04 Nov 2026
- Submission of Certificate obtained from Statutory Auditors in terms of Regulation 169(5) of the SEBI ICDR Regulations, 2018 · 03 Nov 2026
- Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 - Krsnaa Diagnostics secures 15 year Cash based PPP project from Municipal corporation of Delhi for Advanced CT Scan and .... · 03 Nov 2026
- Investor Presentation for the Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Press Release - Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half year ended September 30, 2026 · 03 Nov 2026
- Financial Results for Quarter and Half Year ended September 30, 2026 · 02 Nov 2026
